Hoxton Planning & Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $378K | Sell |
2,036
-93
| -4% | -$17.3K | 0.13% | 132 |
|
|
2025
Q1 | $446K | Buy |
2,129
+76
| +4% | +$15.9K | 0.17% | 115 |
|
|
2024
Q4 | $365K | Buy |
2,053
+223
| +12% | +$39.6K | 0.14% | 130 |
|
|
2024
Q3 | $361K | Buy |
1,830
+338
| +23% | +$66.7K | 0.14% | 136 |
|
|
2024
Q2 | $256K | Sell |
1,492
-45
| -3% | -$7.72K | 0.12% | 129 |
|
|
2024
Q1 | $280K | Buy |
1,537
+162
| +12% | +$29.5K | 0.13% | 120 |
|
|
2023
Q4 | $213K | Sell |
1,375
-112
| -8% | -$17.4K | 0.11% | 138 |
|
|
2023
Q3 | $222K | Sell |
1,487
-168
| -10% | -$25.1K | 0.14% | 125 |
|
|
2023
Q2 | $223K | Buy |
1,655
+267
| +19% | +$36K | 0.14% | 132 |
|
|
2023
Q1 | $221K | Sell |
1,388
-20
| -1% | -$3.19K | 0.12% | 145 |
|
|
2022
Q4 | $228K | Buy |
+1,408
| New | +$228K | 0.12% | 143 |
|